Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Klaus Berger"'
Publikováno v:
Stroke. 52(2)
Background and Purpose: Men and women are differently affected by acute ischemic stroke (AIS) in many aspects. Prior studies on sex disparities were limited by moderate sample sizes, varying years of data acquisition, and inconsistent inclusions of c
Autor:
Klaus Berger, Susanne Rode, Kirsten Haas, Peter Hermanek, Christine Matthis, Christoph Burmeister, Günter Seidel, Viktoria Rücker, Peter U. Heuschmann, Hans-Christian Koennecke, Björn Misselwitz, Alfred Janssen
Publikováno v:
Stroke. 51(12)
Background and Purpose: Quality indicators (QI) are an accepted tool to measure performance of hospitals in routine care. We investigated the association between quality of acute stroke care defined by overall adherence to evidence-based QI and early
Autor:
Urs Fischer, Marie-Luise Mono, Hannes Nordmeyer, Ralph Weber, Pasquale Mordasini, Simon Jung, Hakan Sarikaya, René Chapot, Jeffrie Hadisurya, Corrado Bernasconi, Klaus Berger, Tomas Dobrocky, Sebastian Bellwald, Marcel Arnold, Jan Gralla, Christian Paul Stracke
Publikováno v:
Stroke. 48:3282-3288
Background and Purpose— Randomized controlled trials have shown that mechanical thrombectomy (MT) plus best medical treatment improves outcome in stroke patients with large-vessel occlusion in the anterior circulation. Whether direct MT is equally
Autor:
Hans-Christian Koennecke, Uwe Malzahn, Peter U. Heuschmann, Andreas Meisel, Klaus Berger, Georg Walter, Hendrik J. Harms, Sarah Hoffmann, Marianne Kalic
Publikováno v:
Stroke; Vol 43
Stroke
Stroke
Background and Purpose— Poststroke pneumonia is a potentially preventable complication after stroke associated with poor outcome. We developed and externally validated a prognostic score for predicting risk of pneumonia after ischemic stroke. Metho
Autor:
Wolf-Rüdiger Schäbitz, Jürgen Wellmann, E. Bernd Ringelstein, Heike Wersching, Matthias Schilling, Klaus Berger, Jens Minnerup
Publikováno v:
Stroke. 42:2838-2843
Background and Purpose— The European Cooperative Acute Stroke Study (ECASS) III extended the thrombolysis time window for patients with stroke from 3 to 4.5 hours after symptom onset. We investigated the effect of the extended thrombolysis time win
Autor:
Klaus Berger, Pamela M. Rist, Julie E. Buring, Tobias Kurth, J. Michael Gaziano, Carlos S. Kase
Publikováno v:
Stroke. 41:141-146
Background and Purpose— Light-to-moderate alcohol consumption has been associated with reduced risk of total and ischemic stroke. However, data on the relationship between alcohol consumption and functional outcomes from stroke are sparse. Methods
Autor:
Jutta Dierkes, Kurt Hoffmann, Matthias Möhlig, Heiner Boeing, Klaus Berger, Claus Luley, Joachim Spranger, Cornelia Weikert, Dagmar Drogan, Kerstin Klipstein-Grobusch
Publikováno v:
Stroke. 38:2912-2918
Background and Purpose— Data from prospective studies on the associations between B vitamin plasma levels and the risk of stroke are limited. We investigated the individual and combined effects of plasma folate, vitamin B12, and pyridoxal 5-phophat
Autor:
Monique M.B. Breteler, Moniek P.M. de Maat, Monika Stoll, Isabella Kardys, Frauke Friedrichs, Christiane Reitz, Jacqueline C.M. Witteman, Klaus Berger
Publikováno v:
Stroke, 38(8), 2356-2359. Lippincott Williams & Wilkins
Background and Purpose— It remains unclear whether C-reactive protein (CRP) is a serum marker for atherothrombotic disease or a causal factor in the pathogenesis of atherosclerosis. We explored the association between CRP gene variations and cerebr
Autor:
Gregor Kuhlenbäumer, Florian Stögbauer, Rainer Dziewas, Klaus Berger, G.A. Müller, Erich Bernd Ringelstein, Claus Langer, Carsten Konrad, Ralf Junker, Darius G. Nabavi
Publikováno v:
Stroke. 36:9-13
Background and Purpose— Observations in patients with arterial aneurysms, fibromuscular dysplasia, and spontaneous cervical artery dissection (sCAD) indicate that protease inhibitor deficiency might boost the enzymatic destruction of arterial tissu
Autor:
Bernhard Neundoerfer, C Leffmann, Michael Adelmann, Peter Hermanek, Hans-Joachim Buecker-Nott, Klaus Berger, Joachim Röther, Peter L. Kolominsky-Rabas, Bjoern Misselwitz, Peter U. Heuschmann
Publikováno v:
Stroke. 34:1106-1112
Background and Purpose— There is little information about early outcome after intravenous application of tissue-type plasminogen activator (tPA) for stroke patients treated in community-based settings. We investigated the association between tPA th